Solid Biosciences has surged back into the Duchenne muscular dystrophy (DMD) gene therapy race. | Solid Biosciences has ...

We can see that Kits Eyecare does have institutional investors; and they hold a good portion of the company's stock. This suggests some credibility amongst professional investors. But we can't ...

The Trump administration has effectively put a buy rating on Intel’s stock. But that alone won’t get the troubled chip maker out of its jam. Intel’s shares have soared 22% so far this week.

We can see that Kits Eyecare does have institutional investors; and they hold a good portion of the company's stock. This suggests some credibility amongst professional investors. But we can't rely on ...

Nvidia stock (NVDA) clawed back some losses Tuesday after Monday's DeepSeek-fueled 17% crash. At the end of the trading day, Nvidia stock stood 8.9% higher at $128.99. The move helped stoke a ...

For more than two years, the stock market has been virtually unstoppable. Last year, the iconic Dow Jones Industrial Average (DJINDICES: ^DJI), broad-based S&P 500 (SNPINDEX: ^GSPC), and ...

A recap of some of the top stories to read during Tuesday's trading: ...

Although many analysts believe the bull rush can continue in 2025, the stock market has now breached a critical level, something that's occurred only six times in history. Yale Professor Robert ...

UBS Maintains Buy on Trade Desk, Raises Price Target to $148 Analyst ratings measure the expected performance of a stock during a given time period. Analysts and brokerage firms often use ratings ...